Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 2Thoracic 1Other 1Head & Neck 1

Conditions

Rectal Neoplasms 1Prevention of Colorectal Cancer 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 228Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Selenomethionine × Gastrointestinal × Clear all
NCT00625183 2017-11-17

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

Roswell Park Cancer Institute

Phase 2 Terminated
5 enrolled 6 charts
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT01211561 2010-09-29

Colon Cancer Prevention Using Selenium

University of Illinois at Chicago

Phase EARLY_PHASE1 Unknown
50 enrolled
Gastrointestinal

Prevention of Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡